ArticleBlood advances2024

Differentiation syndrome associated with treatment with IDH2 inhibitor enasidenib: pooled analysis from clinical trials.

Pau Montesinos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.